| JTS2200110 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Disposable Import Drug Application | 2022-12-31 | | | | | view |
| JXSS1900012 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Import Drug Application | 2019-03-27 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-01-22 | view |
| JYSB2400206 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2024-09-12 | | | | | view |
| JYSB2000193 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-05-16 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-05-25 | view |
| JYSB2000653 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-12-25 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2021-01-06 | view |
| JYSZ2400034 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | License Renew | 2024-06-21 | | | | | view |
| JTS1900038 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Disposable Import Drug Application | 2019-08-03 | 瑞士罗氏制药有限公司F. Hoffman-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2019-09-04 | view |
| JYSB2000331 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-06-30 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-07-01 | view |
| JYSB2200017 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2022-02-11 | | | | | view |
| JYSB2400207 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2024-09-12 | | | | | view |
| JYSB2000158 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-05-16 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2020-05-15 | view |
| JYSB2000426 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-09-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-09-11 | view |
| JYSZ2400033 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | License Renew | 2024-06-21 | | | | | view |
| JXSS2000016 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Import Drug Application | 2020-05-27 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-26 | view |
| JYSB2400191 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2024-08-26 | | | | | view |
| JYSB2000157 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-05-16 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2020-05-15 | view |
| JYSB2000425 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-09-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-09-11 | view |
| JYSB2300156 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2023-09-12 | | | | | view |
| JXSS2000017 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Import Drug Application | 2020-05-27 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-26 | view |
| JYSB2200018 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2022-02-11 | | | | | view |
